Last reviewed · How we verify

NCT04552938

LVA on Serum Profiling in Patients With Lymphedema

Completed Last updated 17 September 2020
What this trial tests

trial testing pre-LVA in Lymphedema in 26 participants. Completed in 11 September 2020.

Timeline
11 April 2018
Primary endpoint
1 June 2020
11 September 2020

Quick facts

Lead sponsorChang Gung Memorial Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment26
Start date11 April 2018
Primary completion1 June 2020
Estimated completion11 September 2020
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Chang Gung Memorial Hospital

Who can join

Adults 20 to 100, any sex, with Lymphedema. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The correlation between oxidative stress and increased lymphedematous limb volume lacks supporting evidence. Lymphedema patients are prone to cellulitis. This study aims to investigate the link between oxidative stress, limb volume, and cellulitis after supermicrosurgical lymphaticovenous anastomosis (LVA).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Lymphaticovenous Anastomosis Supermicrosurgery Decreases Oxidative Stress and Increases Antioxidant Capacity in the Serum of Lymphedema Patients.
    Yang JC, Huang LH, Wu SC, Kuo PJ, et al · · 2021 · cited 15× · PMID 33917571 · DOI 10.3390/jcm10071540

Verify or expand the search:

Other recruiting trials for Lymphedema

Currently open trials in the same condition.

Other Chang Gung Memorial Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04552938.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing